CellaVision AB (publ) (CLVSF) Stock Price, News & Analysis

Company Overview

CellaVision AB (publ) is a Swedish medical technology firm specializing in the development and sale of digital cell morphology solutions for hematology laboratories. The company’s core business revolves around high-resolution digital microscopy systems and advanced image analysis software designed to automate and streamline the examination of blood and bone marrow smears. By replacing manual microscopy with automated digital workflows, CellaVision helps clinical laboratories improve accuracy, reduce analysis time and enhance diagnostic consistency.

The company’s product portfolio includes the CellaVision® DM series of digital microscopes, which combine high-quality optics and proprietary image-capture cameras to create a comprehensive library of cellular images. Complementing these instruments is the CellaVision® DC range of slide loaders, enabling continuous, unattended analysis of patient samples. CellaVision’s software platforms leverage image recognition algorithms to pre-classify white blood cells and flag abnormal morphologies, facilitating rapid review by laboratory professionals. Optional modules also support integration with laboratory information systems (LIS) and enable remote review and collaboration.

Founded in 1994 in Lund, Sweden, CellaVision has grown from a university spin-out into a global supplier with direct subsidiaries in the United States, Japan and major European markets. The company’s solutions are used in hospitals, commercial laboratories and blood banks across more than 50 countries. CellaVision maintains an extensive distribution network, providing installation, technical support and training services to ensure customers achieve full operational benefits from its digital hematology platforms.

Committed to ongoing innovation, CellaVision invests in research and development to expand its artificial intelligence capabilities and regulatory approvals. The company’s instruments carry CE marking for use in the European Economic Area and have secured FDA clearance for the U.S. market. With headquarters and manufacturing facilities in Lund, along with regional offices worldwide, CellaVision continues to drive the digital transformation of hematology diagnostics.

Key Stats

• Today's Range: $19.28 to $19.28
• 50-Day Range: $19.28 to $19.28
• 52-Week Range: $19.28 to $19.91
• Volume: N/A
• Average Volume: 383 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CLVSF Stock Analysis - Frequently Asked Questions

How have CLVSF shares performed this year?

CellaVision AB (publ)'s stock was trading at $19.91 on January 1st, 2025. Since then, CLVSF shares have decreased by 3.2% and is now trading at $19.2796.

How do I buy shares of CellaVision AB (publ)?

Shares of CLVSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CLVSF
• CIK: N/A
• Web: www.cellavision.com
• Phone: (646) 460-1600
• Fax: N/A
• Employees: 223
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A